Rare diseases
Investigational molecules
Locations
Back to Slovakia8 clinical trials in Devinska Nova Ves, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
SlovakiaA study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese
SlovakiaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
SlovakiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
SlovakiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
SlovakiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
SlovakiaWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
SlovakiaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on lipoprotein reduction and its impact on major cardiovascular events in patients with established heart conditions. Clinical trials are evaluating new therapeutic approaches to reduce cardiovascular risks.
Studies aim to advance treatment options for patients with elevated cardiovascular risk factors.
Ground-breaking research comparing the effectiveness of novel anticoagulants in preventing stroke and systemic embolism in patients with atrial fibrillation. These trials focus on developing safer treatment options.
Investigations seek to establish superior treatment protocols for managing irregular heartbeat conditions.
Comprehensive studies evaluating innovative medications for both primary and secondary prevention of atherosclerotic cardiovascular disease. Research focuses on reducing major adverse cardiovascular events.
These trials aim to establish new standards in preventing cardiovascular complications in high-risk populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
